Simon Baker
Stock Analyst at Redburn Atlantic
(n/a)
# 4,426
Out of 4,829 analysts
8
Total ratings
n/a
Success rate
-15.08%
Average return
Main Sectors:
Stocks Rated by Simon Baker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AUTL Autolus Therapeutics | Upgrades: Buy | $13 | $1.35 | +862.96% | 1 | Nov 15, 2024 | |
| BNTX BioNTech SE | Upgrades: Buy | $165 → $170 | $97.17 | +74.95% | 3 | May 17, 2023 | |
| QGEN Qiagen | Initiates: Buy | n/a | $42.94 | - | 1 | Oct 14, 2021 | |
| ABT Abbott Laboratories | Initiates: Neutral | n/a | $131.99 | - | 1 | Oct 14, 2021 | |
| HOLX Hologic | Initiates: Neutral | n/a | $58.81 | - | 1 | Oct 14, 2021 | |
| FOXA Fox Corporation | Upgrades: Hold | $29 → $24 | $52.42 | -54.22% | 1 | Apr 8, 2020 |
Autolus Therapeutics
Nov 15, 2024
Upgrades: Buy
Price Target: $13
Current: $1.35
Upside: +862.96%
BioNTech SE
May 17, 2023
Upgrades: Buy
Price Target: $165 → $170
Current: $97.17
Upside: +74.95%
Qiagen
Oct 14, 2021
Initiates: Buy
Price Target: n/a
Current: $42.94
Upside: -
Abbott Laboratories
Oct 14, 2021
Initiates: Neutral
Price Target: n/a
Current: $131.99
Upside: -
Hologic
Oct 14, 2021
Initiates: Neutral
Price Target: n/a
Current: $58.81
Upside: -
Fox Corporation
Apr 8, 2020
Upgrades: Hold
Price Target: $29 → $24
Current: $52.42
Upside: -54.22%